Global Biotechnology Congress 2016 (4th in the Series)

This unique international conference provides a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. Many Nobel Laureates and world's renowned experts will participate in the conference.

The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include major research advances in biotechnology, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.

Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate biotechnology communities.

The conference is organized by Eureka Conference.

Welcome Note

The 'Global Biotechnology Congress 2016' would provide eminent scientists the opportunity to present their cutting edge researches in the field of biotechnology and its applications in medicine. A number of Nobel Laureates and leading researchers are expected to participate in this important conference.

Prof. Ferid Murad
Nobel Laureate
Conference Co-President

I would like to welcome the participants to GBC. This should be an exciting event since the leading authorities in their respective fields have agreed to present their latest works during the conference. A large number of students will also be participating in it which should be very educational for them.

Prof. Atta-ur-Rahman, FRS
Conference Co-President

Participating Nobel Laureates, Plenary Speakers & Keynote Speakers in GBC-2016

Conference Tracks

Pharmaceutical Biotechnology

Biopharmaceuticals Discovery (CNS, cancer, cardiovascular, endocrine, immune, systems biology); Vaccines; Antibodies; Protein Engineering; Bioinformatics; Clinical Research/Clinical trials.

Plant and Environment:

Transgenic Plants and Crops; Bioremediation; Microbial Diversity; Bio-monitoring; Photosynthetic Microorganisms; Cyanobacteria and Microalgae; Translational Genomics and Genomics-assisted Breeding.

Industrial and Manufacturing:

Bio-fuels; Energy Crops (cellulosic ethanol industry); Industrial Enzymes; Bioprocess Engineering and Optimization.

Medical Biotechnology

Biopharmaceutical Manufacturing; Diagnostics; Imaging; Pharmacogenomics (personalized medicine); Microarray Technology; Biomarkers; Clinical Research/Clinical trials.

Business Development

Strategic Alliances; Partnering Trends; Product Opportunities; Growth; Business Models and Strategies; Licensing; Merger and Acquisitions; Outsourcing; Venture Capital and Financing; Intellectual Property.

Regenerative Medicine

Stem Cells; Gene Therapy; Tissue Engineering; Cell Based Therapy; Cell Cultivation; Clinical Research/Clinical trials.

Marine Biotechnology

Environment Applications of Marine Biotechnology; Marine Natural Products; Bio products and Bioactive Compounds; Marine Microbiology and Biodiversity; Marine-based Drug Discovery & Development; Genomics and Proteomics of Marine Organisms; Aquatic Microbial Ecology.

Food Biotechnology

Food Microbiology; Recombinant DNA Techniques; Indigenous Food Production; Fermentation Processes; GM Foods; Human Nutrition and Metabolism; Food Safety; Current Status and Future Prospects of Food Biotechnology.

Bio-Safety and Bioethics

Biosafety Regulations; Intellectual Property Rights; Ethical Issues of Human Genome Project, Organs Transplantation and Stem Cell Research; Handling and Disposal of Hazardous Materials.

Nano Biotechnology

Disease Diagnosis; Drug Delivery; Biosensors; Nanofabricated Devices; DNA Nano biotechnology; Lipid Nanotechnology; Future prospects of Nanobiotechnology.

Previous Participants


Prof. Jean-Marie Lehn
(Nobel Laureate)

Prof. Kurt Wuthrich
(Nobel Laureate)

Prof. Robert Huber
(Nobel Laureate)

Prof. Richard R. Ernst
(Nobel Laureate)

Prof. Werner Arber
(Nobel Laureate)

Prof. Erwin Neher
(Nobel Laureate)

Prof. Klaus Von Klitzing
(Nobel Laureate)

Prof. Harald Zur Hausen
(Nobel Laureate)

Prof. Hartmut Michel
(Nobel Laureate)

Prof. Mario Molina
(Nobel Laureate)

Prof. Sir Harold Kroto
(Nobel Laureate)

Prof. Edmond H. Fischer
(Nobel Laureate)

Prof. Paul Greengard
(Nobel Laureate)

Prof. K. Barry Sharpless
(Nobel Laureate)

Prof. Yuan T. Le
(Nobel Laureate)

Prof. Zhores I. Alferov
(Nobel Laureate)

Prof. James Cronin
(Nobel Laureate)

Prof. Johann Deisenhofer
(Nobel Laureate)

Prof. John Robert Schrieffer
(Nobel Laureate)

Prof. Martinus J.G. Veltman
(Nobel Laureate)

Prof. J. Robin Warren
(Nobel Laureate)

Prof. Louis J.Ignarro
(Nobel Laureate)

Prof. Kary B. Mullis
(Nobel Laureate)

Prof. Ferid Murad
(Nobel Laureate)

Prof. Alan Fersht

Prof. Atta-ur-Rahman

Prof. Goverdhan Mehta

Benifits of Attending

Exchange ideas and network with leading biotechnologists and decision makers.

Bring together top international biotechnology professionals presenting cutting-edge discoveries, research and opportunities for new biotech business practices and partnerships.

Participants can gain direct access to a core audience of biotechnology professionals and decision makers, and have increased visibility through branding and networking at the conference.

Obtain a global roundup of Pharmaceutical research capabilities and opportunities.

The conference will feature a commercial exhibition and poster sessions.

Who Should Attend

The conference will attract to a targeted group of scientists and senior international decision makers.

Delegates will have a valuable, informative and positive experience.


Pharmaceutical Scientists

Food, Environmental and Plant Scientists


CEOs, CROs, directors and research associates from the biotechnology industry and academia

Media Partners


7847050 CANADA Inc.

Participants Comments